About 500 reports

  • 1.1 CINV
  • EXECUTIVE SUMMARY

Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides chemotherapy, there...

  • Chemotherapy
  • United States
  • Eisai Co., Ltd.
  • Helsinn Group
  • Holding Co LLC
  • GROWING PREFERENCE FOR CHEMOTHERAPY DRUGS IN DEVELOPING COUNTRIES
  • The Structure of the Market in Focus

About CINV Drugs The launch of extended half-life drugs in the market is expected to substantially improve the adoption rates, owing to their ability to act for prolonged periods of time. For instance, Heron Therapeutics' SUSTOL and Tesaro's VARUBI offer protection against CINV for five days and seven days, respectively. Additionally,...

  • Chemotherapy
  • Eisai Co., Ltd.
  • GlaxoSmithKline plc
  • Helsinn Group
  • Merck & Co., Inc.
  • 2.7.2 Chemotherapy-Induced Neutropenia
  • 2.7.1 Chemotherapy-Induced Nausea and Vomiting

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets Summary Cancer is a disease characterized by abnormal cell growth and uncontrolled proliferation caused by a series of mutations that result in the...

  • Chemotherapy
  • World
  • Amgen Inc.
  • Daiichi Sankyo Company
  • Eli Lilly & Co.
  • Rising number of patients opting for chemotherapy
  • Increase in global awareness about cancer treatments

About Chemotherapy-induced Neutropenia Therapeutics Neutrophils are immunity-inducing white blood cells. Reduction in its number causes neutropenia. Chemotherapy-induced neutropenia occurring during treatment increases patient’s risk of infection and disrupts cancer treatment. Technavio’s analysts forecast the...

  • Chemotherapy
  • Amgen Inc.
  • Intas Pharmaceuticals Ltd.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Chemotherapy
  • 51.45% of the market share comes from chemotherapy

About Bladder Cancer Therapeutics The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the...

  • Chemotherapy
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Pfizer Inc.

Chemotherapy Induced Anemia - Epidemiology Forecast to 2027 ##.

  • Chemotherapy
  • France
  • Germany
  • Italy
  • Spain

Chemotherapy Induced Neutropenia- Epidemiology Forecast to 2027 ##.

  • Chemotherapy
  • France
  • Germany
  • Italy
  • Spain

Chemotherapy Induced Nausea and Vomiting - Epidemiology Forecast to 2027 ##.

  • Chemotherapy
  • France
  • Germany
  • Italy
  • Spain
  • GASTRIC CANCER CASES ON CHEMOTHERAPY
  • Pipeline: Chemotherapy-Induced Anemia

The chemotherapy-induced anemia (CIA) market is expected to grow marginally due to a lack of novel therapies and a static disease population. This report addresses the following questions: - How have developments in cancer treatment impacted the CIA market? - What will the future look like for erythropoiesis-stimulating...

  • Chemotherapy
  • European Union
  • Japan
  • United States
  • Amgen Inc.

Drug A: Company ## ##. ##. ##.

  • Chemotherapy
  • Oncology
  • Therapy
  • United States
  • Market Shares

Drug A: Company ## ##. ##. ##.

  • Chemotherapy
  • Therapy
  • United States
  • Market Shares

Drug A: Company ## ##. ##. ##.

  • Blood Disease
  • Chemotherapy
  • Therapy
  • United States
  • Market Shares

Chemotherapy Induced Neutropenia- Epidemiology Insights to 2023 Report Introduction Snapshot of Total Prevalent or Incident cases by ## MM Executive Summary Key Findings Chemotherapy Induced Neutropenia Overview Chemotherapy Induced Neutropenia Definition Pathophysiology S

  • Chemotherapy
  • France
  • Germany
  • Italy
  • Japan

Chemotherapy Induced Neutropenia (CIN) Market Size Assumptions and Caveats ##.

  • Cancer
  • Chemotherapy
  • Pathology
  • Therapy
  • United States
  • Chemotherapy-induced anemia
  • Chemotherapy-induced neutropenia

About Cancer Supportive Care Cancer supportive care drugs are used for the treatment of adverse effects caused due to the cancer treatment such as chemotherapy-induced anemia, CINV, bone metastasis, cancer pain, and others. Various class of drugs are used as cancer supportive care drugs. Some of the major drug class that involves...

  • Blood Disease
  • Chemotherapy
  • Amgen Inc.
  • Helsinn Group
  • Merck & Co., Inc.
  • 6.1.1 CHEMOTHERAPY
  • Cancer Therapy Market: Revenue in USD million, by Chemotherapy, Global, 2015-2023

The global cancer therapy market is expected to register a CAGR of 6.5% during the forecast period, 2018 to 2023. North America dominates the market, due to growing prevalence of cancer diseases and rapid adoption of new therapy and novel drugs in the region. High Prevalence and Incidence of Cancer Disease Worldwide Cancer is...

  • Chemotherapy
  • United States
  • Amgen Inc.
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • 6.1 By Chemotherapy
  • 5.2 RESTRAINTS

The global acute myeloid leukemia market is expected to register a CAGR of 14% during the forecast period of 2018-2023. Due to the higher awareness of the condition and the drugs that treat it, and continued acceptance toward existing therapeutics, North America dominates the market studied. High Incidence and Prevalence of Acute Myeloid...

  • Chemotherapy
  • Celgene Corporation
  • Eisai Co., Ltd.
  • Genmab group
  • Novartis AG
  • Chemotherapy
  • Chemotherapy

The Global market for infusion pump is growing at a steady pace. The global infusion pump market is expected to reach USD 9710.2 million by 2023 from USD 6534.2 in 2016 with a CAGR of 5% during the forecast period. Various factors that supports the growth of the market are; increased use of infusion pumps for the delivery of drugs and other...

  • Chemotherapy
  • World
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Property Group
  • Chemotherapies
  • 7.4 CHEMOTHERAPIES

PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2026 Summary Prostate cancer (PCa) is the second most common cancer in men worldwide, after skin cancer. It accounts for 12% of all the cancers diagnosed in men, and thus represents a huge burden on healthcare systems. While...

  • Chemotherapy
  • Hormone
  • Prostate Cancer
  • Therapy
  • PROVENGE group
  • CHEMOTHERAPY
  • Global Kaposi sarcoma chemotherapy market 2016-2021 ($ millions)

About Kaposi Sarcoma Kaposi sarcoma is a multicentral tumor. The tumor is caused by Kaposi sarcoma-associated herpesvirus (KSHV) also known as human herpesvirus 8 (HHV8). It can occur as endemic, classic, epidemic, and iatrogenic forms. Epidemic or acquired immune deficiency syndrome (AIDS)-associated form of treatment is...

  • Chemotherapy
  • Forecast
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Export of Unilateral Chemotherapy Drug
  • Import of Unilateral Chemotherapy Drug

This study focuses on China’s Lubricating Oil Additive industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of...

  • Chemotherapy
  • China
  • Demand
  • Market Size
  • Trade
  • Export of Unilateral Chemotherapy Drug
  • Import of Unilateral Chemotherapy Drug

China’s demand for Low Density Polyethylene (LDPE) has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...

  • Chemotherapy
  • China
  • Demand
  • Trade
  • Sanofi-Synthelabo Inc.
  • 8.4 EFFECTIVE ALTERNATIVES TO CHEMOTHERAPY
  • AVERAGE COST OF THERAPY OF GENERIC CHEMOTHERAPY IN THE 8MM

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. Today, HER2-positive breast cancer patients are living longer with their disease, thanks to established...

  • Chemotherapy
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • Chemotherapy
  • Availability of chemotherapy and off-label drugs

About the Solid Tumors Drugs Market The rising prevalence of various cancers, which has led to innovations and technological advancements, drives the development of new immunotherapy drugs that are more effective than the available drugs to treat solid tumors. Solid tumors are an abnormal mass of tissue that do not contain cysts...

  • Chemotherapy
  • World
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Pfizer Inc.
  • AVERAGE COST PER CYCLE OF CHEMOTHERAPY REGIMENS IN THE 8MM
  • SHOWS THE AVERAGE COST PER CYCLE OF CHEMOTHERAPY REGIMENS IN THE 8MM.

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected to experience a moderate growth between 2015 and 2025. The main drivers of growth will be the expected increased...

  • Chemotherapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • Chemotherapy Drugs
  • Chemotherapy Drugs

This study focuses on China’s Generic Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Chemotherapy
  • China
  • Demand
  • Forecast
  • Market Size
  • Chemotherapy Drugs Sales Volume
  • Chemotherapy Drugs Sales Volume

This study focuses on China’s Skin Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Import of Chemotherapy Drug
  • Chemotherapy Drug Sales Volume and Market Share

This study focuses on China’s Liver Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Chemotherapy
  • China
  • Demand
  • Trade
  • Hainan Haiyao Company Limited
  • Import of Chemotherapy Drug
  • Import of Chemotherapy Drug

China’s demand for Liver Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Chemotherapy
  • China
  • Demand
  • Novartis AG
  • Sanofi-Synthelabo Inc.
  • Chemotherapy Drugs Sales Volume
  • Chemotherapy Drugs Sales Volume by Drugs

China’s demand for Skin Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.